|
Real-time Estimate
Cboe BZX
11:38:54 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 19.74 USD | -1.08% |
|
-3.17% | -25.57% |
| 09-28 | Neuren Says US Patent Allowance Could Extend Trofinetide Protection to 2041 | MT |
| 09-28 | Acadia Pharmaceuticals Gets US Patent Office Allowance for Trofinetide Dosing Patent | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.08% | -3.17% | -27.92% | -22.86% | -25.57% | -7.92% | -9.47% | +17.49% | -31.00% | 3.44B | |
| +4.16% | +3.04% | +8.78% | +34.82% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.16B | |
| -0.37% | -3.81% | -6.56% | -0.07% | +13.34% | +19.51% | +78.12% | +213.91% | +5,294.42% | 57.39B | |
| +1.41% | -1.81% | +2.32% | -1.17% | +6.66% | +2.94% | +36.60% | -17.87% | +210.22% | 47.64B | |
| -1.25% | +1.33% | -1.39% | +7.60% | +156.66% | +338.88% | +709.30% | +629.33% | - | 44.29B | |
| +1.95% | -3.10% | +1.29% | +27.47% | +16.48% | +28.07% | +32.73% | +9.69% | +226.00% | 42.5B | |
| +0.20% | -2.60% | +1.70% | +15.51% | +17.66% | +3.75% | +109.45% | +2.91% | +1,028.35% | 40.71B | |
| -0.54% | +2.93% | -2.92% | -0.54% | +5.93% | +9.31% | +54.06% | -10.44% | +140.38% | 30.97B | |
| +1.56% | +4.53% | +12.65% | +47.50% | +76.21% | +31.34% | +26.92% | -52.08% | - | 28.53B | |
| -0.34% | -3.16% | -2.75% | +2.15% | +0.79% | -8.76% | -12.65% | -61.64% | - | 24.34B | |
| -6.20% | -12.02% | -17.11% | -7.19% | -40.52% | -34.59% | +313.44% | +290.07% | +586.05% | 24.27B | |
| +5.32% | +3.26% | +11.02% | +30.07% | +17.27% | +12.18% | -3.02% | -14.09% | +110.35% | 20.32B | |
| +2.47% | -0.65% | +3.56% | +8.29% | +8.95% | +15.39% | +150.72% | +216.57% | +1,932.33% | 16.73B | |
| +2.15% | +3.03% | -9.16% | -5.37% | +180.86% | +136.14% | +365.04% | +1,731.11% | +651.23% | 15.16B | |
| +0.22% | -0.48% | -15.23% | -14.55% | - | - | - | - | - | 14.96B | |
| +0.91% | -4.04% | +5.50% | +9.96% | +21.06% | +21.56% | +44.77% | -28.86% | +83.57% | 14.63B | |
| -0.06% | -0.03% | +1.18% | +5.08% | +33.13% | +45.84% | +163.55% | +179.05% | +344.74% | 14.47B | |
| -0.51% | +0.60% | -4.00% | -5.85% | +19.79% | -16.33% | +508.94% | - | - | 14.38B | |
| +4.49% | +2.43% | +7.47% | +30.38% | +51.26% | +72.47% | +57.85% | -24.82% | +263.67% | 13.85B | |
| +6.41% | -4.50% | +26.38% | +33.86% | +37.60% | -12.71% | - | - | - | 13.83B | |
| Average | +1.07% | -1.52% | -0.26% | +9.75% | +35.90% | +37.18% | +151.14% | +181.76% | +833.87% | 27.83B | |
| Weighted average by Cap. | +1.09% | -1.28% | +1.02% | +13.06% | +41.66% | +47.12% | +150.29% | +147.50% | +1,280.77% |
- Stock Market
- Stocks
- ACAD Stock
- Sector Acadia Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
